Incidence of and predictive factors for lung cancer in patients with rheumatoid arthritis: A retrospective long-term follow-up study
Modern Rheumatology · 21.02.2025 · 35 (2) · 240-248
DOI: 10.1093/mr/roae084 ↗Kurz gefasst
Fachartikel in der Zeitschrift Modern Rheumatology, online erschienen am 03.09.2024. Verfasst von Shunsuke Mori und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology, Clinical Research Center for Rheumatic Diseases, National Hospital Organization (NHO) Kumamoto Saishun Medical Center, Ko…. Hauptthemen laut MEDLINE: Arthritis, Rheumatoid, Lung Neoplasms, Pulmonary Fibrosis. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Objectives
The aim of this study was to determine the incidence and predictive factors of lung cancer in rheumatoid arthritis (RA).
Methods
We conducted a retrospective follow-up study of patients who were diagnosed with RA at our institution between April 2001 and December 2022. Pulmonary complications were evaluated using high-resolution computed tomography (HRCT) at RA diagnosis. Patients were followed until the diagnosis of lung cancer, diagnosis of other malignancies, death, loss to follow-up, or the end of the study.
Results
Among 771 RA patients, 3.5% were diagnosed with combined pulmonary fibrosis and emphysema (CPFE), 4.9% with interstitial lung disease (ILD) alone, and 6.0% with emphysema alone. During follow-up (mean of 9.3 years), the crude incidence rates of lung cancer per 1000 patient-years were 2.9 in all patients, 47.8 in CPFE patients, 10.5 in ILD patients, 11.9 in emphysema patients, and 0.8 in patients without these complications. Only male patients showed a higher incidence of lung cancer compared with the general population. In multivariable Fine–Gray regression analysis, the presence of HRCT-proven CPFE, ILD, and emphysema, and smoking history were identified as predictive factors for lung cancer in RA patients.
Conclusions
Close monitoring of lung cancer is needed for RA patients with smoking history and pulmonary complications, especially CPFE.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Rheumatology, Clinical Research Center for Rheumatic Diseases, National Hospital Organization (NHO) Kumamoto Saishun Medical Center, Kohshi, Kumamoto, Japan.
- Department of Respiratory Medicine, Tokyo Women's Medical University Yachiyo Medical Center, Yachiyo, Chiba, Japan.
- Department of Radiology, Kanagawa Cardiovascular and Respiratory Center, Yokohama, Kanagawa, Japan.
- Department of Radiology, NHO Kumamoto Saishun Medical Center, Kohshi, Kumamoto, Japan.
- Department of Respiratory Medicine, NHO Kumamoto Saishun Medical Center, Kohshi, Kumamoto, Japan.
ORCID-Profile: Shunsuke Mori
Zitieren
APA
Mori, S., Hasegawa, M., Sakai, F., Nakashima, K., & Nakamura, K. (2025). Incidence of and predictive factors for lung cancer in patients with rheumatoid arthritis: A retrospective long-term follow-up study. Modern Rheumatology, 35(2), 240-248. https://doi.org/10.1093/mr/roae084
Vancouver
Mori S, Hasegawa M, Sakai F, Nakashima K, Nakamura K. Incidence of and predictive factors for lung cancer in patients with rheumatoid arthritis: A retrospective long-term follow-up study. Modern Rheumatology. 2025;35(2):240-248. doi:10.1093/mr/roae084
BibTeX
@article{Mori2025,
author = {Mori, Shunsuke and Hasegawa, Mizue and Sakai, Fumikazu and Nakashima, Kouya and Nakamura, Kazuyoshi},
title = {Incidence of and predictive factors for lung cancer in patients with rheumatoid arthritis: A retrospective long-term follow-up study},
journal = {Modern Rheumatology},
year = {2025},
volume = {35},
number = {2},
pages = {240--248},
doi = {10.1093/mr/roae084}
}
EUVIMED